Intrinsic Myogenic Potential of Skeletal Muscle-Derived Pericytes from Patients with Myotonic Dystrophy Type 1

De Angelis, 1999, Skeletal myogenic progenitors originating from embryonic dorsal aorta coexpress endothelial and myogenic markers and contribute to postnatal muscle growth and regeneration, J. Cell Biol., 147, 869, 10.1083/jcb.147.4.869 Minasi, 2002, The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues, Development, 129, 2773, 10.1242/dev.129.11.2773 Dellavalle, 2007, Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells, Nat. Cell Biol., 9, 255, 10.1038/ncb1542 Birbrair, 2015, Pericytes are essential for skeletal muscle formation, Stem Cell Rev. Rep., 11, 547, 10.1007/s12015-015-9588-6 Kostallari, 2015, Pericytes in the myovascular niche promote post-natal myofiber growth and satellite cell quiescence, Development, 142, 1242 Dellavalle, 2011, Pericytes resident in postnatal skeletal muscle differentiate into muscle fibres and generate satellite cells, Nat. Commun., 2, 499, 10.1038/ncomms1508 Berry, 2015, Concise review: mesoangioblast and mesenchymal stem cell therapy for muscular dystrophy: progress, challenges, and future directions, Stem Cells Transl. Med., 4, 91, 10.5966/sctm.2014-0060 Sampaolesi, 2006, Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs, Nature, 444, 574, 10.1038/nature05282 Galvez, 2006, Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability, J. Cell Biol., 174, 231, 10.1083/jcb.200512085 Morosetti, 2011, Mesoangioblasts from facioscapulohumeral muscular dystrophy display in vivo a variable myogenic ability predictable by their in vitro behavior, Cell Transplant., 20, 1299, 10.3727/096368910X546571 Quattrocelli, 2012, Mouse and human mesoangioblasts: isolation and characterization from adult skeletal muscles, Methods Mol. Biol., 798, 65, 10.1007/978-1-61779-343-1_4 Mateos-Aierdi, 2015, Muscle wasting in myotonic dystrophies: a model of premature aging, Front. Aging Neurosci., 7, 125, 10.3389/fnagi.2015.00125 Wertz, 1981, Patients with myotonic dystrophy, a possible segmental progeroid syndrome, and Duchenne muscular dystrophy have fibroblasts with normal limits for in vitro lifespan and growth characteristics, J. Cell. Physiol., 107, 255, 10.1002/jcp.1041070212 Rotini, 2018, Aging affects the in vivo regenerative potential of human mesoangioblasts, Aging Cell, 10.1111/acel.12714 Mulders, 2010, Molecular therapy in myotonic dystrophy: focus on RNA gain-of-function, Hum. Mol. Genet., 19, R90, 10.1093/hmg/ddq161 Gudde, 2017, Antisense transcription of the myotonic dystrophy locus yields low-abundant RNAs with and without (CAG)n repeat, RNA Biol., 14, 1374, 10.1080/15476286.2017.1279787 Gudde, 2016, A low absolute number of expanded transcripts is involved in myotonic dystrophy type 1 manifestation in muscle, Hum. Mol. Genet., 25, 1648, 10.1093/hmg/ddw042 Pearson, 2005, Repeat instability: mechanisms of dynamic mutations, Nat. Rev. Genet., 6, 729, 10.1038/nrg1689 Mirkin, 2007, Expandable DNA repeats and human disease, Nature, 447, 932, 10.1038/nature05977 Zu, 2011, Non-ATG-initiated translation directed by microsatellite expansions, Proc. Natl. Acad. Sci. USA, 108, 260, 10.1073/pnas.1013343108 Zhang, 2018, Stress granule assembly disrupts nucleocytoplasmic transport, Cell, 173, 958, 10.1016/j.cell.2018.03.025 Udd, 2012, The myotonic dystrophies: molecular, clinical, and therapeutic challenges, Lancet Neurol., 11, 891, 10.1016/S1474-4422(12)70204-1 Jansen, 1996, Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice, Nat. Genet., 13, 316, 10.1038/ng0796-316 Harmon, 2008, Myotonic dystrophy protein kinase is expressed in embryonic myocytes and is required for myotube formation, Dev. Dyn., 237, 2353, 10.1002/dvdy.21653 Tedesco, 2010, Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells, J. Clin. Invest., 120, 11, 10.1172/JCI40373 Pierantozzi, 2016, Tissue-specific cultured human pericytes: perivascular cells from smooth muscle tissue have restricted mesodermal differentiation ability, Stem Cells Dev., 25, 674, 10.1089/scd.2015.0336 Valadares, 2014, Human adipose tissue derived pericytes increase life span in Utrn (tm1Ked) Dmd (mdx) /J mice, Stem Cell Rev Rep, 10, 830, 10.1007/s12015-014-9537-9 Seznec, 2000, Transgenic mice carrying large human genomic sequences with expanded CTG repeat mimic closely the DM CTG repeat intergenerational and somatic instability, Hum. Mol. Genet., 9, 1185, 10.1093/hmg/9.8.1185 Gomes-Pereira, 2007, CTG trinucleotide repeat “big jumps”: large expansions, small mice, PLoS Genet., 3, e52, 10.1371/journal.pgen.0030052 Huguet, 2012, Molecular, physiological, and motor performance defects in DMSXL mice carrying >1,000 CTG repeats from the human DM1 locus, PLoS Genet., 8, e1003043, 10.1371/journal.pgen.1003043 Mathieu, 2001, Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy, Neurology, 56, 336, 10.1212/WNL.56.3.336 Nirwane, 2017, Isolation of Type I and Type II Pericytes from Mouse Skeletal Muscles, J Vis. Exp., 123, e55904 Sicot, 2011, Myotonic dystrophy, when simple repeats reveal complex pathogenic entities: new findings and future challenges, Hum. Mol. Genet., 20, R116, 10.1093/hmg/ddr343 André, 2018, Abnormalities in skeletal muscle myogenesis, growth, and regeneration in myotonic dystrophy, Front. Neurol., 9, 368, 10.3389/fneur.2018.00368 Gladman, 2013, Age of onset of RNA toxicity influences phenotypic severity: evidence from an inducible mouse model of myotonic dystrophy (DM1), PLoS ONE, 8, e72907, 10.1371/journal.pone.0072907 Tonlorenzi, 2007, Isolation and characterization of mesoangioblasts from mouse, dog, and human tissues, Curr. Protoc. Stem Cell Biol., 3, 10.1002/9780470151808.sc02b01s3 Safadi, 1991, Activity of alkaline phosphatase in rat skeletal muscle localized along the sarcolemma and endothelial cell membranes, J. Histochem. Cytochem., 39, 199, 10.1177/39.2.1987264 Murakami, 2010, Comparison of capillary architecture between slow and fast muscles in rats using a confocal laser scanning microscope, Acta Med. Okayama, 64, 11 Thornell, 2009, Satellite cell dysfunction contributes to the progressive muscle atrophy in myotonic dystrophy type 1, Neuropathol. Appl. Neurobiol., 35, 603, 10.1111/j.1365-2990.2009.01014.x van Dijk, 2015, The complex mural cell: pericyte function in health and disease, Int. J. Cardiol., 190, 75, 10.1016/j.ijcard.2015.03.258 Hughes, 2006, Altered pericyte-endothelial relations in the rat retina during aging: implications for vessel stability, Neurobiol. Aging, 27, 1838, 10.1016/j.neurobiolaging.2005.10.021 Murray, 2017, Skeletal and cardiac muscle pericytes: functions and therapeutic potential, Pharmacol. Ther., 171, 65, 10.1016/j.pharmthera.2016.09.005 Hellström, 1999, Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse, Development, 126, 3047, 10.1242/dev.126.14.3047 Hughes, 2004, Characterization of smooth muscle cell and pericyte differentiation in the rat retina in vivo, Invest. Ophthalmol. Vis. Sci., 45, 2795, 10.1167/iovs.03-1312 Morales, 2015, Parental age effects, but no evidence for an intrauterine effect in the transmission of myotonic dystrophy type 1, Eur. J. Hum. Genet., 23, 646, 10.1038/ejhg.2014.138 Larsson, 2010, In situ detection and genotyping of individual mRNA molecules, Nat. Methods, 7, 395, 10.1038/nmeth.1448 Ishikawa, 2019, Morphology-based analysis of myoblasts for prediction of myotube formation, SLAS Discov., 24, 47, 10.1177/2472555218793374 Morosetti, 2011, Mesoangioblasts of inclusion-body myositis: a twofold tool to study pathogenic mechanisms and enhance defective muscle regeneration, Acta Myol., 30, 24 Morosetti, 2007, Isolation and characterization of mesoangioblasts from facioscapulohumeral muscular dystrophy muscle biopsies, Stem Cells, 25, 3173, 10.1634/stemcells.2007-0465 van Agtmaal, 2017, CRISPR/Cas9-induced (CTG⋅CAG)n repeat instability in the myotonic dystrophy type 1 locus: implications for therapeutic genome editing, Mol. Ther., 25, 24, 10.1016/j.ymthe.2016.10.014 Larsen, 2011, Myoblasts generated by lentiviral mediated MyoD transduction of myotonic dystrophy type 1 (DM1) fibroblasts can be used for assays of therapeutic molecules, BMC Res. Notes, 4, 490, 10.1186/1756-0500-4-490 Dastidar, 2018, Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells, Nucleic Acids Res., 46, 8275, 10.1093/nar/gky548 Péault, 2007, Stem and progenitor cells in skeletal muscle development, maintenance, and therapy, Mol. Ther., 15, 867, 10.1038/mt.sj.6300145 Sampaolesi, 2003, Cell therapy of α-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts, Science, 301, 487, 10.1126/science.1082254 Cossu, 2015, Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy, EMBO Mol. Med., 7, 1513, 10.15252/emmm.201505636 Gourdon, 1997, Moderate intergenerational and somatic instability of a 55-CTG repeat in transgenic mice, Nat. Genet., 15, 190, 10.1038/ng0297-190 Braz, 2018, Of Mice and Men: advances in the understanding of neuromuscular aspects of myotonic dystrophy, Front. Neurol., 9, 519, 10.3389/fneur.2018.00519 Voermans, 2009, Neuromuscular involvement in various types of Ehlers-Danlos syndrome, Ann. Neurol., 65, 687, 10.1002/ana.21643